Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

722

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Dry Eye Disease

Interventions

DRUG

Difluprednate 0.05% ophthalmic emulsion

Topical ocular steroid

OTHER

Difluprednate vehicle

Inactive ingredients used as Run-In and placebo comparator

Trial Locations (1)

Contact Alcon Call Center at 1-888-451-3937 for Trial Locations, Fort Worth